Deficiencies and excessive human complement system activation in disorders of multifarious etiology
- PMID: 23214307
Deficiencies and excessive human complement system activation in disorders of multifarious etiology
Abstract
Complement is an integral part of the immune system protecting the host organism against invasion and proliferation of various microorganisms. It is also involved in the removal of the body's own damaged and altered cells. Activation of the complement system is a very precise process and it is strictly controlled by regulatory proteins present in both plasma and at host cells' surfaces. C3 protein plays a major role in the complement activation and generation of immune responses. Deficiencies of the C3 and other complement components, so-called early and late complement proteins, contribute to the emergence of recurrent bacterial, viral and fungal infections. The low level of mannose-binding lectin is also important. This protein plays a protective role in the early stages of infection and in the control of inflammation. Its deficit is one of the most common reasons for human immunodeficiency, observed in microbial infections as well as in autoimmune diseases such as rheumatoid arthritis. On the other hand, the excessive activation of complement proteins is often discovered to be the reason for many diseases. These include e.g. autoimmune diseases, Alzheimer's syndrome, schizophrenia, atypical hemolytic-uremic syndrome, angioedema, macular degeneration, and Crohn's disease.
Similar articles
-
Complement-related diseases.Allergy Asthma Proc. 2002 Sep-Oct;23(5):319-24. Allergy Asthma Proc. 2002. PMID: 12476541 Review.
-
Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.Adv Immunol. 2007;96:141-77. doi: 10.1016/S0065-2776(07)96004-6. Adv Immunol. 2007. PMID: 17981206 Review.
-
Complement in health and disease.Adv Drug Deliv Rev. 2011 Sep 16;63(12):965-75. doi: 10.1016/j.addr.2011.06.005. Epub 2011 Jun 16. Adv Drug Deliv Rev. 2011. PMID: 21704094 Review.
-
Inherited complement component abnormalities.Annu Rev Med. 1986;37:333-46. doi: 10.1146/annurev.me.37.020186.002001. Annu Rev Med. 1986. PMID: 3010807 Review.
-
Complement disorders and hereditary angioedema.J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S262-71. doi: 10.1016/j.jaci.2009.10.063. J Allergy Clin Immunol. 2010. PMID: 20176263 Review.
Cited by
-
Cross-platform proteomics signatures of extreme old age.bioRxiv [Preprint]. 2024 Apr 14:2024.04.10.588876. doi: 10.1101/2024.04.10.588876. bioRxiv. 2024. Update in: Geroscience. 2024 Jul 25. doi: 10.1007/s11357-024-01286-x PMID: 38645061 Free PMC article. Updated. Preprint.
-
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD.Ann Hematol. 2023 Dec;102(12):3299-3309. doi: 10.1007/s00277-023-05439-4. Epub 2023 Oct 10. Ann Hematol. 2023. PMID: 37817009 Free PMC article.
-
Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H.Front Psychiatry. 2023 Jul 13;14:1146714. doi: 10.3389/fpsyt.2023.1146714. eCollection 2023. Front Psychiatry. 2023. PMID: 37520223 Free PMC article.
-
The Exploration of Complement-Resistance Mechanisms of Pathogenic Gram-Negative Bacteria to Support the Development of Novel Therapeutics.Pathogens. 2022 Aug 18;11(8):931. doi: 10.3390/pathogens11080931. Pathogens. 2022. PMID: 36015050 Free PMC article. Review.
-
Tick Salivary Compounds for Targeted Immunomodulatory Therapy.Front Immunol. 2020 Sep 23;11:583845. doi: 10.3389/fimmu.2020.583845. eCollection 2020. Front Immunol. 2020. PMID: 33072132 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
